Open Clinical Trials
Englewood Hospital’s physician-investigators are currently recruiting research subjects for participation in several clinical trials across various departments.
Anesthesiology
REGAIN: A Randomized Controlled Trial of Regional versus General Anesthesia for Promoting Independence After Hip Fracture
Principal Investigator: Gregg Lobel, MD
Coordinator: Sungrok “Aaron” Chang
Phone: 201-894-3163
NCT #: 02057505
Englewood Health IRB #: E-15-637
More Information (clinicaltrials.gov)
Cardiology
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve through Implantation of ACURATE in Subjects InDicatEd for TAVR
Principal Investigator: Joseph De Gregorio, MD
Coordinator: Beatriz Sosa
Phone: 201-608-2663
NCT #: 03735667
Englewood Health IRB #: E-21-860
More Information (clinicaltrials.gov)
Champion AF: WATCHMAN FLX versus NOAC for Embolic Protection in the Management of Patients with Non-Valvular Atrial Fibrillation
Principal Investigator: Grant Simons, MD
Coordinator: Sungrok “Aaron” Chang
Phone: 201-894-3163
NCT #: 04394546
Englewood Health IRB #: E-20-839
More Information (clinicaltrials.gov)
Gastroenterology
A Phase 2 Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study to Evaluate the Safety and Efficacy of Oral PN-943 in Subjects with Moderate to Severe Active Ulcerative Colitis
Principal Investigator: Mark Sapienza, MD
Coordinator: Sungrok “Aaron” Chang
Phone: 201-894-3163
NCT #: 04504383
Englewood Health IRB #: E-20-824
More Information (clinicaltrials.gov)
Gastroenterology / C Diff
Fecal Microbiota Transplantation (FMT) for the Treatment of Recurrent or Refractory Clostridium Difficile Infection (CDI)
Principal Investigator: Marc Fiorillo, MD
Coordinator: Sungrok “Aaron” Chang
Phone: 201-894-3163
NCT #: 01942447
Englewood Health IRB #: E-13-507
More Information (clinicaltrials.gov)
Gynecology
A randomized controlled trial to evaluate the efficacy of acupuncture versus aromatherapy as treatments to lessen nausea and vomiting associated with Adriamycin and Cytoxan
Principal Investigator: Tracy Scheller, MD
Coordinator: Nathalia Clark
Phone: 201-894-3088
NCT #: 04116697
Englewood Health IRB #: E-19-773
More Information (clinicaltrials.gov)
Oncology
Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients With Advanced Stage Cancer
Principal Investigator: Vinnidhy Dave, DO
Coordinator: Nathalia Clark
Phone: 201-894-3088
NCT #: 05170919
Englewood Health IRB #: E-21-862
More Information (clinicaltrials.gov)
EAZ171: Prospective validation trial of taxane therapy (docetaxel or weekly paclitaxel) and risk of chemotherapy-induced peripheral neuropathy in African American women
Principal Investigator: Jill Morrison, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04001829
Englewood Health IRB #: E-19-794
More Information (clinicaltrials.gov)
Oncology / Bladder Cancer
A phase II study of dose-dense gemcitabine plus cisplatin (ddGC) in patients with muscle-invasive bladder cancer with bladder preservation for those patients whose tumors harbor deleterios DNA damage response (DDR) gene alterations
Principal Investigator: Brian Kim, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 03609216
Englewood Health IRB #: E-18-748
More Information (clinicaltrials.gov)
Oncology / Breast Cancer
A011202: A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Principal Investigator: David Dubin, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 01901094
Englewood Health IRB #: E-18-749
More Information (clinicaltrials.gov)
A011401: Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer
Principal Investigator: Jill Morrison, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 02750826
Englewood Health IRB #: E-16-663
More Information (clinicaltrials.gov)
B-51: Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Principal Investigator: David Dubin, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 01872975
Englewood Health IRB #: E-16-651
More Information (clinicaltrials.gov)
COMET: Comparison Of Operative To Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS: A Phase III Prospective Randomized Trial
Principal Investigator: Steven Brower, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 02926911
Englewood Health IRB #: E-17-710
More Information (clinicaltrials.gov)
Oncology / Colon Cancer
A021502: Randomized Trial of Standard Chemotherapy alone or combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer with Deficient DNA Mismatch (ATOMIC: Adjuvant Trial of Deficient Mismatch Repair in Colon Cancer)
Principal Investigator: Minaxi Jhawer, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 02912559
Englewood Health IRB #: E-18-752
More Information (clinicaltrials.gov)
A021703: Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)
Principal Investigator: Minaxi Jhawer, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 04094688
Englewood Health IRB #: E-19-792
More Information (clinicaltrials.gov)
Oncology / Colorectal Cancer
A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination with or without Atezolizumab or Atezolizumab Monotherapy in First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal Cancer
Principal Investigator: Minaxi Jhawer, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 02997228
Englewood Health IRB #: E-18-753
More Information (clinicaltrials.gov)
Oncology / Gastric Cancer
IMIGASTRIC II: Prospective, observational, multicenter study on minimally invasive gastrectomy for gastric cancer: robotic, laparoscopic and open surgery compared on operative and follow-up outcomes
Principal Investigator: Steven Brower, MD
Coordinator: Anna Feiler
Phone: 201-894-3917
NCT #: 02751086
Englewood Health IRB #: E-16-673
More Information (clinicaltrials.gov)
Oncology / Neuroendocrine
A021602 Advanced Neuroendocrine Tumors: “A021602, Randomized, Double-Blinded Phase III Study of Cabozantinib Versus Placebo in Patients with Advanced Neuroendocrine Tumors after Progression on Everolimus (CABINET)
Principal Investigator: Minaxi Jhawer, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 03375320
Englewood Health IRB #: E-18-754
More Information (clinicaltrials.gov)
Oncology / Renal Cancer
EA8143: A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients with Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
Principal Investigator: Maz Ganat, MD
Coordinator: Audrey Ades
Phone: 201-894-3603
NCT #: 03055013
Englewood Health IRB #: E-19-784
More Information (clinicaltrials.gov)
Vascular Surgery
Intravascular Ultrasound-Guided Intervention for Venous Leg Ulcers (IGuideU)
Principal Investigator: Steven Elias, MD
Coordinator: Sungrok “Aaron” Chang
Phone: 201-894-3163
NCT #: 04696354
Englewood Health IRB #: E-21-854
More Information (clinicaltrials.gov)
The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis (SAVVE) Study
Principal Investigator: Steven Elias, MD
Coordinator: Nathalia Clark
Phone: 201-894-3088
NCT #: 04943172
Englewood Health IRB #: E-21-855
More Information (clinicaltrials.gov)
VIVID: Venous stent for the Iliofemoral Vein Investigational clinical trial using DUO™ Venous Stent System
Principal Investigator: Steven Elias, MD
Coordinator: Sungrok “Aaron” Chang
Phone: 201-894-3163
NCT #: 04580160
Englewood Health IRB #: E-20-838
More Information (clinicaltrials.gov)